Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of 24 Weeks Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder With Comorbid Opioid Use Disorder - A Multicenter Randomized, Double-blind, Placebo-controlled Study
Conditions
Interventions
Sustained-release Dexamphetamine
Placebo
Start Date
May 1, 2026
Primary Completion Date
January 1, 2029
Completion Date
October 1, 2029
Last Updated
March 19, 2026
NCT07071779
NCT04721418
NCT05011760
NCT06125054
NCT06701487
NCT07532460
Lead Sponsor
Parnassia Addiction Research Centre
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions